, Tracking Stock Market Picks
Enter Symbol:

down 99.98 %

BIONOVO INC (BNVI) rated Buy with price target $3.50 by Canaccord Adams

Posted on: Tuesday,  Apr 1, 2008  11:25 AM ET by Canaccord Adams

Canaccord Adams rated Buy BIONOVO INC (OTCBB: BNVIQ) on 04/01/2008, when the stock price was $6.45. Since
then, BIONOVO INC has lost 99.99% as of 08/14/2015's recent price of $0.00.
If you would have followed this Canaccord Adams's recommendation on BNVIQ, you would have lost 99.98% of your investment in 2691 days.

Bionovo, Inc. is a clinical stage drug discovery and development company focusing on women?s health and cancer. The Company designs drugs derived from botanical sources, which have mechanisms of action. The Company?s drug candidate, Menerba, represents a class of receptor sub-type selective estrogen receptor modulator (SERM) for the treatment of vasomotor symptoms of menopause, or hot flashes. The Company has designed Menerba to selectively modulate estrogen receptor beta (ERβ). In preclinical studies, Menerba inhibited tumor growth, as well as bone resorption known to cause osteoporosis, which is developed during menopause. The Company was developing BZL101, an oral anti-cancer agent for advanced breast cancer during the year ended December 31, 2008. BZL101 is designed to take advantage of the metabolism of cancer cells. BZL101 inhibits glycolysis, a metabolic pathway on which cancer cells rely.

Canaccord Adams provides focused, actionable, idea-driven research, helping clients make informed investment decisions. Our 55 international analysts scour the globe for emerging and small to mid cap (US$1-2 billion market capitalization) growth opportunities, identifying value and exposing risk. Our research team analyzes over 550 companies in eight sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. Our clients benefit from our thorough and sophisticated knowledge of the sectors we cover - Metals and Mining, Energy, Technology, Life Sciences, Real Estate, Consumer, Sustainability and Industrial Growth. We combine independent, actionable ideas, unique global perspective and unparalleled industry expertise. We believe it's evident in our research, and the foundation of our business.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/1/2008 11:25 AM Buy
6.45 17.50
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy